|
TMEM66 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.48969999999682E-05 |
| Normal-vs-Stage3 |
4.08960000000125E-05 |
| Normal-vs-Stage4 |
8.795100E-03 |
| Stage1-vs-Stage2 |
8.329600E-01 |
| Stage1-vs-Stage3 |
1.406390E-02 |
| Stage1-vs-Stage4 |
2.231800E-04 |
| Stage2-vs-Stage3 |
1.645590E-01 |
| Stage2-vs-Stage4 |
2.607700E-02 |
| Stage3-vs-Stage4 |
3.081200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
6.801000E-04 |
| Normal-vs-Asian |
8.617800E-01 |
| Caucasian-vs-AfricanAmerican |
3.636100E-02 |
| Caucasian-vs-Asian |
1.286590E-01 |
| AfricanAmerican-vs-Asian |
2.829800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.73727698893344E-12 |
| Normal-vs-Female |
2.22044604925031E-16 |
| Male-vs-Female |
1.192390E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.859200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.62736490949555E-12 |
| Normal-vs-Age(61-80Yrs) |
1.34225963677181E-13 |
| Normal-vs-Age(81-100Yrs) |
6.304200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.085900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.155590E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.023610E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.519400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.030600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.014200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.981970E-04 |
| Normal-vs-Grade 2 |
1.62447832963153E-12 |
| Normal-vs-Grade 3 |
3.50750539723776E-11 |
| Normal-vs-Grade 4 |
5.774400E-01 |
| Grade 1-vs-Grade 2 |
8.930100E-02 |
| Grade 1-vs-Grade 3 |
9.809200E-04 |
| Grade 1-vs-Grade 4 |
2.52869999994854E-06 |
| Grade 2-vs-Grade 3 |
4.982500E-04 |
| Grade 2-vs-Grade 4 |
1.27400000549116E-08 |
| Grade 3-vs-Grade 4 |
2.358900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
6.685500E-02 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.64601665630926E-12 |
| Normal-vs-N1 |
8.415200E-01 |
| N0-vs-N1 |
1.389860E-02 |
|
|
